Literature DB >> 15365033

In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine.

Lidiane Meire Kohler1, Paulo César Fialho Monteiro, Rosane Christine Hahn, Júnia Soares Hamdan.   

Abstract

Thirty isolates of the yeast form of Sporothrix schenckii were evaluated for in vitro susceptibility to itraconazole and terbinafine by the recommended NCCLS modified technique (M27-A2). The MICs of itraconazole obtained oscillated between 0.062 and 4.0 microg/ml, and those of terbinafine oscillated between 0.007 and 0.50 microg/ml; therefore, terbinafine showed greater in vitro activity.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15365033      PMCID： PMC516298          DOI： 10.1128/JCM.42.9.4319-4320.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

Review 1.  Sporotrichosis.

Authors:  T De Araujo; A C Marques; F Kerdel
Journal:  Int J Dermatol       Date:  2001-12       Impact factor: 2.736

Review 2.  Case report. Sporotrichosis successfully treated with itraconazole in Japan.

Authors:  H Noguchi; M Hiruma; A Kawada
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

3.  Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones.

Authors:  J Heeres; L J Backx; J Van Cutsem
Journal:  J Med Chem       Date:  1984-07       Impact factor: 7.446

4.  Effects of three azole derivatives on the lipids of different strains of Sporothrix schenckii.

Authors:  A K Casali; J S Hamdan
Journal:  Can J Microbiol       Date:  1997-12       Impact factor: 2.419

5.  In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.

Authors:  A Espinel-Ingroff
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  Activity of terbinafine against serious fungal pathogens.

Authors:  N S Ryder
Journal:  Mycoses       Date:  1999       Impact factor: 4.377

7.  Treatment of cutaneous sporotrichosis with terbinafine.

Authors:  P R Hull; H F Vismer
Journal:  Br J Dermatol       Date:  1992-02       Impact factor: 9.302

8.  Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis.

Authors:  S W Chapman; P Pappas; C Kauffmann; E B Smith; R Dietze; N Tiraboschi-Foss; A Restrepo; A B Bustamante; C Opper; S Emady-Azar; R Bakshi
Journal:  Mycoses       Date:  2004-02       Impact factor: 4.377

9.  Efficacies of four antifungal agents in experimental murine sporotrichosis.

Authors:  V L Kan; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191
View more
  10 in total

1.  In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases.

Authors:  Luciana Trilles; Belkys Fernández-Torres; Márcia Dos Santos Lazéra; Bodo Wanke; Armando de Oliveira Schubach; Rodrigo de Almeida Paes; Isabel Inza; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

2.  Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.

Authors:  A Espinel-Ingroff; D P B Abreu; R Almeida-Paes; R S N Brilhante; A Chakrabarti; A Chowdhary; F Hagen; S Córdoba; G M Gonzalez; N P Govender; J Guarro; E M Johnson; S E Kidd; S A Pereira; A M Rodrigues; S Rozental; M W Szeszs; R Ballesté Alaniz; A Bonifaz; L X Bonfietti; L P Borba-Santos; J Capilla; A L Colombo; M Dolande; M G Isla; M S C Melhem; A C Mesa-Arango; M M E Oliveira; M M Panizo; Z Pires de Camargo; R M Zancope-Oliveira; J F Meis; J Turnidge
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 3.  Successful Treatment of Canine Sporotrichosis with Terbinafine: Case Reports and Literature Review.

Authors:  Paula Gonçalves Viana; Anna Barreto Fernandes Figueiredo; Isabella Dib Ferreira Gremião; Luisa Helena Monteiro de Miranda; Isabela Maria da Silva Antonio; Jéssica Sepulveda Boechat; Ana Caroline de Sá Machado; Manoel Marques Evangelista de Oliveira; Sandro Antonio Pereira
Journal:  Mycopathologia       Date:  2017-12-08       Impact factor: 2.574

4.  Antifungal susceptibilities of Sporothrix albicans, S. brasiliensis, and S. luriei of the S. schenckii complex identified in Brazil.

Authors:  Daniele C Oliveira; Paulo G Markus Lopes; Tatiana B Spader; Camila D Mahl; Giordano R Tronco-Alves; Valeria M Lara; Janio M Santurio; Sydney Hartz Alves
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

5.  Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.

Authors:  Jéssica Sepulveda Boechat; Sandro Antonio Pereira; Ana Caroline de Sá Machado; Paula Gonçalves Viana; Rodrigo Almeida-Paes; Rosely Maria Zancopé-Oliveira; Isabella Dib Ferreira Gremião; Manoel Marques Evangelista de Oliveira
Journal:  Braz J Microbiol       Date:  2020-07-02       Impact factor: 2.476

Review 6.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

7.  Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis.

Authors:  Glaucia Francesconi; Antonio Carlos Francesconi do Valle; Sonia Lambert Passos; Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; André Luiz Land Curi; José Liporage; Cássio Ferreira Porto; Maria Clara Gutierrez Galhardo
Journal:  Mycopathologia       Date:  2010-11-21       Impact factor: 2.574

8.  Influence of different media, incubation times, and temperatures for determining the MICs of seven antifungal agents against Paracoccidioides brasiliensis by microdilution.

Authors:  R C Cruz; S M C Werneck; C S Oliveira; P C Santos; B M Soares; D A Santos; P S Cisalpino
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

9.  Morphological and physiological comparison of taxa comprising the Sporothrix schenckii complex.

Authors:  Ming-dan Zhao; Xun Zhou; Ting-ting Liu; Zhi-bang Yang
Journal:  J Zhejiang Univ Sci B       Date:  2015-11       Impact factor: 3.066

Review 10.  Sporotrichosis: an overview and therapeutic options.

Authors:  Vikram K Mahajan
Journal:  Dermatol Res Pract       Date:  2014-12-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.